Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus

ET Iwamoto

Department of Pharmacology, University of Kentucky College of Medicine, Lexington.

The antinociceptive effect of subcortically administered nicotine was investigated in the rat using the hot-plate and tail-flick tests. Adult male Sprague-Dawley rats were implanted with guide cannulas aimed at 185 sites in the forebrain, midbrain and hindbrain. After 1 week, nicotine was injected in 0.5 microliter of 50 mM phosphate buffer, pH 7.4. The pedunculopontine tegmental nucleus (PPTg) of the mesopontine tegmentum and the nucleus raphe magnus (NRM) of the ventral medulla were the most sensitive sites of nicotine-induced antinociception. The median effective doses of nicotine to inhibit hot-plate or tail-flick nociception after PPTg or NRM administration ranged between 1.4 and 3 nmol. The lack of effect of s.c. injections of naloxone on the antinociception induced by nicotine in the PPTg or NRM ruled out endogenous opioid mechanisms. Coadministration of mecamylamine or pirenzepine with nicotine into the NRM competitively antagonized nicotine-induced antinociception. The administration of the muscurinic cholinergic type 2 receptor antagonist methoctramine into the NRM produced a strong antinociceptive response which was blocked by prior treatment of the NRM with hemicholinium-3. Hemicholinium-3 pretreatment of either the PPTg or the NRM antagonized the antinociception induced by nicotine at these sites. Hemicholinium-3 pretreatment of the NRM also antagonized the antinociception produced by s.c. administered nicotine. The antinociceptive effects of nicotine injected in the PPTg were blocked by procainamide injections in the NRM; however, the antinociceptive effects of nicotine injected in the NRM were not blocked by bilateral injections of procainamide in the PPTg. Both lesioning the PPTg with ibotenic acid and pretreating the NRM with hemicholinium-3 abolished completely the antinociception induced by nicotine or (+)-cis-dioxolane microinjections into the PPTg. However, neither ibotenic acid-induced nor electrolytic lesions of the PPTg alone altered CRL. The data support the existence of a tonically active cholinergic pathway which is under autoinhibitory control that originates in the PPTg, terminates in the NRM and modulates nociception by activating descending pain inhibitory systems relaying within the NRM.

Volume 257, Issue 1, pp. 120-133, 04/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. I. Damaj Nicotinic Regulation of Calcium/Calmodulin-Dependent Protein Kinase II Activation in the Spinal Cord J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 244 - 249. [Abstract] [Full Text] [PDF]

				S. Fucile, A. Sucapane, and F. Eusebi Ca2+ permeability of nicotinic acetylcholine receptors from rat dorsal root ganglion neurones J. Physiol., May 15, 2005; 565(1): 219 - 228. [Abstract] [Full Text] [PDF]

				G. Cucchiaro, N. Chaijale, and K. G. Commons The Dorsal Raphe Nucleus as a Site of Action of the Antinociceptive and Behavioral Effects of the {alpha}4 Nicotinic Receptor Agonist Epibatidine J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 389 - 394. [Abstract] [Full Text] [PDF]

				M. I. Damaj, P. Flood, K. K. Ho, E. L. May, and B. R. Martin Effect of Dextrometorphan and Dextrorphan on Nicotine and Neuronal Nicotinic Receptors: In Vitro and in Vivo Selectivity J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 780 - 785. [Abstract] [Full Text] [PDF]

				H.-C. Ma, S. Dohi, Y.-F. Wang, Y. Ishizawa, and F. Yanagidate The Antinociceptive and Sedative Effects of Carbachol and Oxycodone Administered into Brainstem Pontine Reticular Formation and Spinal Subarachnoid Space in Rats Anesth. Analg., May 1, 2001; 92(5): 1307 - 1315. [Abstract] [Full Text] [PDF]

				I. M. Khan, S. Stanislaus, L. Zhang, P. Taylor, and T. L. Yaksh A-85380 and Epibatidine Each Interact with Disparate Spinal Nicotinic Receptor Subtypes to Achieve Analgesia and Nociception J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 230 - 239. [Abstract] [Full Text]

				M. Cordero-Erausquin and J.-P. Changeux Tonic nicotinic modulation of serotoninergic transmission in the spinal cord PNAS, February 15, 2001; (2001) 41600698. [Abstract] [Full Text]

				S. L. Jinks and E. Carstens Activation of Spinal Wide Dynamic Range Neurons by Intracutaneous Microinjection of Nicotine J Neurophysiol, December 1, 1999; 82(6): 3046 - 3055. [Abstract] [Full Text] [PDF]

				P. Curzon, A. L. Nikkel, A. W. Bannon, S. P. Arneric, and M. W. Decker Differences Between the Antinociceptive Effects of the Cholinergic Channel Activators A-85380 and (±)-Epibatidine in Rats J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 847 - 853. [Abstract] [Full Text]

				R. S. Bitner, A. L. Nikkel, P. Curzon, S. P. Arneric, A. W. Bannon, and M. W. Decker Role of the Nucleus Raphe Magnus in Antinociception Produced by ABT-594: Immediate Early Gene Responses Possibly Linked to Neuronal Nicotinic Acetylcholine Receptors on Serotonergic Neurons J. Neurosci., July 15, 1998; 18(14): 5426 - 5432. [Abstract] [Full Text] [PDF]

				A. W. Bannon, M. W. Decker, M. W. Holladay, P. Curzon, D. Donnelly-Roberts, P. S. Puttfarcken, R. S. Bitner, A. Diaz, A. H. Dickenson, R. D. Porsolt, et al. Broad-Spectrum, Non-Opioid Analgesic Activity by Selective Modulation of Neuronal Nicotinic Acetylcholine Receptors Science, January 2, 1998; 279(5347): 77 - 80. [Abstract] [Full Text]

				D. McGehee, M. Heath, S Gelber, P Devay, and L. Role Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors Science, September 22, 1995; 269(5231): 1692 - 1696. [Abstract] [PDF]

				M. Cordero-Erausquin and J.-P. Changeux Tonic nicotinic modulation of serotoninergic transmission in the spinal cord PNAS, February 27, 2001; 98(5): 2803 - 2807. [Abstract] [Full Text] [PDF]